Ion channel

Details for Australian Patent Application No. 2005238272 (hide)

Owner Paradigm Therapeutics Limited

Inventors Brice, Nicola; Carlton, Mark; Zahn, Dirk; Malinge, Isabelle; Dixon, John

Agent Davies Collison Cave

Pub. Number AU-A-2005238272

PCT Pub. Number WO2005/105838

Priority 0409504.8 28.04.04 GB; 0422290.7 07.10.04 GB; 60/575,626 28.05.04 US; 60/617,870 12.10.04 US

Filing date 28 April 2005

Wipo publication date 10 November 2005

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/105838 Priority application(s): WO2005/105838

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238274-Crystalline and amorphous forms of smilagenin

2005238271-Preparation of nanoparticle materials